About Assertio (ASRT)
Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Susp... Read more
- USD0.66
- USD0.68
- USD0.65
- USD1.80
- 1.10%
- 119M
- 72.98k
- 247.71k
- 64M
- 0.51
- -34.30%
Stock News
2 hours ago
EVgo got the attention of a major investment bank. There’s plenty to like — along with 3 roadblocks.
MarketWatch
2 hours ago
Meta's energy deal boosts the data center trade, sending our newest stock to another record high
CNBC
2 hours ago
Goldman Sachs starts coverage on auto services stock with mixed ratings
Yahoo
3 hours ago
Buy Now Pay Later services can hurt consumers, says CFP: Some users are 'playing with fire'
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
